Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
about
Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceProtein C inhibitor--a novel antimicrobial agentDecreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axisProtease-armed bacteria in the skin.The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors.Corruption of innate immunity by bacterial proteases.Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin.Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A StreptococcusAgents that inhibit bacterial biofilm formation.M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition.Postpartum group a Streptococcus sepsis and maternal immunology.Polymorphisms in regulator of protease B (RopB) alter disease phenotype and strain virulence of serotype M3 group A StreptococcusStreptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope PhysiologyCationic antimicrobial peptide resistance mechanisms of streptococcal pathogens.Vitamin D's potential to reduce the risk of hospital-acquired infections.Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infectionVitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cellsStructural and functional analysis of RopB: a major virulence regulator in Streptococcus pyogenes.Bacterial Evasion of Host Antimicrobial Peptide DefensesCationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal.Induction of group A Streptococcus virulence by a human antimicrobial peptide.Intrauterine group A streptococcal infections are exacerbated by prostaglandin E2.Biofilm in group A streptococcal necrotizing soft tissue infections.HMGB1 in severe soft tissue infections caused by Streptococcus pyogenesThe globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication.Bacterial resistance mechanisms against host defense peptides.Bacterial resistance to cationic antimicrobial peptides.Failure of respiratory defenses in the pathogenesis of bacterial pneumonia of cattle.Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens.Streptococcal toxins: role in pathogenesis and disease.The detrimental impact of extracellular bacterial proteases on wound healing.The majority of 9,729 group A streptococcus strains causing disease secrete SpeB cysteine protease: pathogenesis implications.Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae).Dynamics of speB mRNA transcripts in Streptococcus pyogenes.Signaling by a Conserved Quorum Sensing Pathway Contributes to Growth Ex Vivo and Oropharyngeal Colonization of Human Pathogen Group A Streptococcus.
P2860
Q26991811-6588F10D-83CF-4953-A39F-D6F4405DF013Q28268083-EA56DDBB-75AA-4B13-8E9F-95416573179EQ33640337-4B964AD9-944D-4B7B-B027-D5D56529E0CBQ34256463-A0B84A53-D643-430F-B19A-40DF162B81BCQ34774620-C30B3734-A69B-4EA3-A4E1-92D496947F20Q35003110-A27D33D9-7B5D-499A-BD11-1E0DDE1D5E20Q35329635-8B54ACDF-01F9-43AD-A0DB-BFF4529BA6A6Q35559866-86E8381B-E699-4B29-B365-AE5BBF4926F2Q35617082-BD2CF148-1E19-4537-AA0A-8953981E013EQ35621805-635DA9CD-E7E1-4315-87F2-8F2398DB7D4BQ35658832-55FC4007-7F66-4C9C-85BF-2D4C907A2834Q35662035-C12604D2-7B1B-4536-8FCC-5E6C134F5A04Q35814379-998FF7BF-19D6-4778-B365-412F4E7EB32FQ35963490-E35001E1-4FB7-4230-A195-2D92083DEB68Q36187615-A65B6914-D4DA-41EF-B232-4ABE956EFF89Q36326757-187D89D5-3550-4992-9F33-7F1061C8B530Q36351482-1D7CD92C-5E06-4C9F-9234-0DBEE1C1C5BEQ36694367-3D8896E2-F10A-416B-8FA4-0E45A01401D7Q36720179-E62D77C1-32E1-45BC-85F9-CBE69A0859CDQ36822969-B5577338-BB63-4ABA-87B2-0759864B1704Q36954965-D081F8EB-17CD-42E0-A964-C4DFF32F1C46Q37112427-F93538A4-076C-4317-A41D-832E88C52C76Q37277336-5A024761-EAC4-4542-A445-D24F320C5A34Q37531146-AB3A9D54-86E2-4470-935C-014F9A3DD5B9Q37570257-D2E1A5F3-1109-4EF5-8F93-08C758DC0D50Q37874201-DDEB036F-57B3-4157-A82A-46C534158182Q38026594-DDFDDFFF-BD07-4EB3-8145-432A5F864FABQ38136000-7E34C843-FAF6-4440-BAA8-2072B892F9CCQ38227102-D263FE28-7C8A-42E7-A363-6A1B0BEA7962Q38598360-33BAB89F-9083-46F3-A456-357C74E82900Q39458904-7C34CDEA-F7C5-4D88-9DF3-2654208C8B70Q40488735-36950387-517B-4047-803C-FAA4EC8F64CDQ42018382-84D6552E-B4E9-4EDF-8DA3-DB1071D5D001Q42052167-83ABD519-92F4-4B1E-A35E-FAF73B976908Q52659580-618C53AA-BA55-4C25-AC13-FB516B9B1786
P2860
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
@ast
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
@en
type
label
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
@ast
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
@en
prefLabel
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
@ast
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
@en
P2093
P2860
P356
P1476
Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans
@en
P2093
Adam Linder
Anna Norrby-Teglund
Donald E Low
Erika Hertzén
Linda Johansson
Parham Sendi
Per Akesson
Pontus Thulin
P2860
P304
P356
10.1128/IAI.01392-07
P407
P577
2008-05-19T00:00:00Z